Ana Banito

8.5k total citations · 1 hit paper
27 papers, 3.5k citations indexed

About

Ana Banito is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ana Banito has authored 27 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Ana Banito's work include Sarcoma Diagnosis and Treatment (8 papers), Cancer-related Molecular Pathways (6 papers) and Telomeres, Telomerase, and Senescence (6 papers). Ana Banito is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Cancer-related Molecular Pathways (6 papers) and Telomeres, Telomerase, and Senescence (6 papers). Ana Banito collaborates with scholars based in United States, United Kingdom and Germany. Ana Banito's co-authors include Jesús Gil, Juan Carlos Acosta, Selina Raguz, Ana O’Loghlen, Marco Da Costa, David Bernard, Eva Hernando, Marzia Fumagalli, Yoshihiro Takatsu and Fabrizio d’Adda di Fagagna and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Ana Banito

25 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence

2008 1.4k citations Juan Carlos Acosta, Ana O’Loghlen et al. Cell profile →

Peers

Ana Banito

PHYSI

IMMUN

ONCOL

Juan Carlos Acosta United Kingdom

Liesbeth C.W. Vredeveld Netherlands

Marta Barradas Spain

Marzia Fumagalli Italy

Denise P. Muñoz United States

Kentaro Hosokawa Japan

Arnaud Augert France

Sirith Douma Netherlands

Eva González‐Suárez Spain

Angelo Cicalese Italy

Juan Carlos Acosta United Kingdom

Ana Banito

2.3k ×1.0

1.4k ×1.1

PHYSI

861 ×1.2

IMMUN

745 ×1.2

ONCOL

538 ×1.1

Citations per year, relative to Ana Banito Ana Banito (= 1×) peers Juan Carlos Acosta

Countries citing papers authored by Ana Banito

Since Specialization

Citations

This map shows the geographic impact of Ana Banito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Banito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Banito more than expected).

Fields of papers citing papers by Ana Banito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Banito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Banito. The network helps show where Ana Banito may publish in the future.

Co-authorship network of co-authors of Ana Banito

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Banito. A scholar is included among the top collaborators of Ana Banito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Banito. Ana Banito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benabdallah, Nezha S., Li Li, Jinxiu Li, et al.. (2025). DNA demethylating agents suppress preclinical models of synovial sarcoma. Journal of Clinical Investigation. 135(13). 1 indexed citations

Will, Rainer, Dominic Helm, Felix Bestvater, et al.. (2025). Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma. Cancer Communications. 45(5). 494–499.

Benabdallah, Nezha S., R. Wilder Scott, F. Kommoss, et al.. (2023). Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability. Nature Structural & Molecular Biology. 30(11). 1640–1652. 11 indexed citations

Zhu, Changyu, Yadira M. Soto-Feliciano, John P. Morris, et al.. (2023). MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer. eLife. 12. 13 indexed citations

Huang, Chun‐Hao, Francisco J. Sánchez‐Rivera, Margaret C. Kennedy, et al.. (2022). A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets. Proceedings of the National Academy of Sciences. 119(17). e2110557119–e2110557119. 8 indexed citations

Li, Jinxiu, Jared J. Barrott, Mary L. Nelson, et al.. (2021). A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18–SSX Induces Canonical BAF Destruction. Cancer Discovery. 11(10). 2620–2637. 32 indexed citations

Kommoss, F., Kenneth Tou En Chang, Damian Stichel, et al.. (2020). Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications. The Journal of Pathology Clinical Research. 6(3). 178–184. 36 indexed citations

Loizou, Evangelia, Ana Banito, Geulah Livshits, et al.. (2019). A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1. Cancer Discovery. 9(7). 962–979. 59 indexed citations

Jones, David, Ana Banito, Thomas G. P. Grünewald, et al.. (2019). Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours. Nature reviews. Cancer. 19(8). 420–438. 85 indexed citations

10.

Banito, Ana, Xiang Li, Jae‐Seok Roe, et al.. (2018). The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell. 33(3). 527–541.e8. 101 indexed citations

11.

Aarts, Marieke, Athena Georgilis, Meryam Beniazza, et al.. (2017). Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence. Genes & Development. 31(20). 2085–2098. 45 indexed citations

12.

Tasdemir, Nilgun, Ana Banito, Jae‐Seok Roe, et al.. (2016). BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance. Cancer Discovery. 6(6). 612–629. 278 indexed citations

13.

Tschaharganeh, Darjus F., Wen Xue, Diego F. Calvisi, et al.. (2016). p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer. Cell. 165(6). 1546–1547. 21 indexed citations

14.

Marqués‐Torrejón, María Ángeles, Eva Porlan, Ana Banito, et al.. (2012). Cyclin-Dependent Kinase Inhibitor p21 Controls Adult Neural Stem Cell Expansion by Regulating Sox2 Gene Expression. Cell stem cell. 12(1). 88–100. 170 indexed citations

15.

Banito, Ana & Jesús Gil. (2010). Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Reports. 11(5). 353–359. 83 indexed citations

16.

Barradas, Marta, Emma Anderton, Juan Carlos Acosta, et al.. (2009). Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes & Development. 23(10). 1177–1182. 271 indexed citations

17.

Banito, Ana, S. Tamir Rashid, Juan Carlos Acosta, et al.. (2009). Senescence impairs successful reprogramming to pluripotent stem cells. Genes & Development. 23(18). 2134–2139. 489 indexed citations

18.

Cavaco, Branca, Carmo Martins, Ana Banito, et al.. (2008). Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocrine Related Cancer. 15(1). 207–215. 48 indexed citations

19.

Acosta, Juan Carlos, Ana O’Loghlen, Ana Banito, et al.. (2008). Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence. Cell. 133(6). 1006–1018. 1374 indexed citations breakdown →

20.

Banito, Ana, António E. Pinto, Carla Espadinha, Ana Rita Marques, & Valeriano Leite. (2007). Aneuploidy and RAS mutations are mutually exclusive events in the development of well‐differentiated thyroid follicular tumours. Clinical Endocrinology. 67(5). 706–711. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact